SBF HealthCare: Providing the Healing Touch

Once you choose hope, anything is possible- Christopher Reeve

It is often said that hope is the ability to see light despite all the darkness around and this could not be more relevant than in the context of cancer care. As most people are aware, cancer is a disease unlike any other and the road from diagnosis to treatment and cure can be an arduous one. A primary challenge here is the fact that every kind of cancer is different and hence there is no “one-size-fits-all” cure. Bringing in a beacon of hope in the light of this scenario is SBF Healthcare, an organization dedicated to providing excellent medical services and a pioneer in cancer related medical research.

Standard Treatments

Cancer is a group of diseases that is characterized by unusual cell multiplication. It is a disease characterized by the development of abnormal cells that divide uncontrollably and have the ability to infiltrate and destroy normal body tissue. Statistics show that every year about 850,000 new cancer cases are diagnosed in India, of which more than 60% of the patients are in the prime of their life i.e. between the ages of 35 – 65 years.

Cancer research that has been underway for more than 200 years has made tremendous progress in the recent years. The present standard options of treatment are surgery , chemotherapy and radiation therapy. It is key to note that each of them have a multitude of side effects that take a toll on the body leaving the immune system highly compromised. Hence for years now scientists all over the world have been researching and looking to devise a therapy bereft of side effects; one that will be a novel, safe and relatively less harsh way of treating cancer.

SPMF Therapy

SBF Health Care brings to you SPMF therapy which is the world’s first scientifically proven, non-invasive treatment for cancer without side effects. The therapy uses the technology of Sequentially Programmed Magnetic Fields (SPMF) and has been pioneered and patented by WG CDR (Dr) V G Vasishta, a former professor and head at the institute of Aerospace Medicine, Indian Air Force.

After conducting research on cancer cells for over 40 years, Dr. Vasishta has an immense understanding of these cells and the way they function. He has spearheaded the clinical trials which have shown remarkable results on cancer patients and helped improve their quality of life. “SPMF therapy is a non-surgical treatment mechanism that halts the progression of the disease without causing any pain or discomfort to the patient. Studies have shown that magnetic fields at a certain frequency cause an antitumor effect while leaving the normal cells unaffected. “ SPMF Therapy has proven to be effective with localised cancers such as brain tumours, pancreatic cancer and prostate cancers to name a few” says Dr. Vasishta.

Promising results

The results have been encouraging and SBF Healthcare has treated over 10,000 cases with positive results for both arthritis and cancer using this therapy. “SPMF therapy is a focused form of treatment and we are actively looking to help improve the quality of life of our patients. More importantly there are no side effects on the body” adds Dr. Vasishta.

With SPMF therapy, SBF Healthcare is making the right impact on cancer care and offering the much-needed hope to suffering patients . It is helping them stay positive which is ultimately the best medicine.

Details and Contact:

● Address: 1st Floor, 25/7 Shree Kote Asirwad Towers, Doddanekundi, Outer ring road, bangalore 560037

● Phone: +919900548375

● Email: info@sbfhealthcare.com

● Website: http://www.sbfhealthcare.com/

City Today News
9341997936

MSME Aerospace and Defense Expo to be held in Bengaluru

  • Shri B S Yediyurappa, Chief Minister of Karnataka announced the event during inaugural function of AERO INDIA 2021.
  • The event will be held from 27th to 29th September 2021 at Bengaluru International Exhibition Center
  • The three-day event will be organized by Laghu Udyog Bharati and IMS Foundation in association with Government of Karnataka
Shri B S Yediyurappa, Chief Minister of Karnataka – inaugural function of AERO INDIA 2021

Bengaluru, February 3, 2021: The Hon’ble Chief Minister of Karnataka, Shri B S Yeddiyurappa, today announcedthe MSME Aerospace and Defense Expo as a part of the India Manufacturing Show. The fifth edition of this biennial event will be held in Bengaluru, from 27 – 29September 2021. The event will be organized by Laghu Udyog Bharati – Karnataka (LUB-K) and IMS Foundation in association with the Government of Karnataka.

During his inaugural address at the AERO INDIA Show Shri B S Yediyurappa, CM of Karnataka said, “As you are aware that Hon’ble Prime Minister Shri Narendra Modi ji wants MSMEs to play a very important role in AtmaNirbhar Bharat Abhiyan. To realize his dream, Laghu Udyog Bharati and IMS foundation with the support of Government of Karnataka is organizing MSME Aerospace and Defense Expo from 27th to 29th September 2021 at Bengaluru International Exhibition Centre. I request Hon’ble Shri Rajnath Singh ji to extend full support of Defense Ministry to make this event a grand success.”

Shri Rajnath Singh, Union Minister of Defense said, “India today offers unique opportunity in Aerospace and Defense manufacturing. Domestic manufacturing of rare and complex Defense platforms has now become the focus of our policy under Atmanirbhar Bharat Abhiyan. We encourage global OEMs to set up their own manufacturing facility or enter into a strategic partnership with Indian companies. India is steadily marching from Make in India towards Make for the World. We have a strong and diversified micro small and medium enterprises sector with more than 85,000 units. We also have one of the fastest growing start-up ecosystems catering to niche technologies.”

The three-day expo spread over 20,000 m² will be the largest exhibition for Micro Small and Medium Enterprises in Aerospace and Defense industry. IMS 2021 will provide opportunity to MSMEs from diverse Industry sectors like Auto Industry, Industrial Engineering, Electronics and Automation etc. IMS 2021 will also host Vendor Development Program, B2B meetings and Workshops. The event will be supported by Indo German Chamber of Commerce as well as leading Industry bodies of India.

The Chairman of India Manufacturing Show and former National President of LUB, Mr H V S Krishna said, “We met the Hon’ble Defense Minister, Shri Rajnath Singh Ji and he in-principle has agreed to extend full support of defense ministry to this show. We are expecting over 500 exhibitors, 20000 business delegates and 150 experts addressing conference and workshops and VDPs. The participants in the event will include leaders from large defense global and Indian OEMs, Defense PSUs and Ordinance Factories as well as DRDO Labs. We are also glad that Hon’ble CM has declared complete support of government of Karnataka to this event.”

City Today News
9341997936

BMTC is providing safe, reliable and affordable transport facility for the visitors of Aero India-2021

Transport facility for the visitors of Aero India-2021 show

BMTC is providing safe, reliable and affordable transport facility for the convenience of travelling public in and around Bengaluru city. Aero India-2021 show is organized by Government of India at Yelahanka Air Force Station, Bengaluru from 03-02-2021 to 05-02-2021. BMTC, with a view to provide transport facility to the visitors of Aero India-2021 show, will operate adequate buses from Kempegowda Bus Station and Yelahanka Bus Station on above said dates, as per passengers demand by following the COVID-19 guidelines.

Public Relations Officer

City Today News
9341997936

Dr. G.S.K. Velu appointed as new Chairman, FICCI Tamil Nadu State Council for the year 2021

Tuesday, February 2, 2021: Renowned healthcare entrepreneur, Dr. G.S.K. Velu has been appointed as the Chairperson of Federation of Indian Chambers of Commerce and Industry (FICCI), Tamil Nadu State Council. Prior to this, he co-chaired the FICCI Tamil Nadu State Council.

Driven by the vision to make medical technology, expertise and quality healthcare available to all, Dr. Velu has been promoting high-value health technology and diagnostics offerings through his business initiatives. Currently, he is the Chairman & Managing Director at Neuberg Diagnostics, a global pathology brand operating in India, UAE and South Africa; Chairman & Managing Director at Trivitron Healthcare, a prominent medical technology company; Mentor & Shareholder at Kauvery Group of Hospitals, a chain of multi-specialty Hospitals; Chairman at Maxivision Eye Hospitals, a national chain of eye care super-specialty hospitals; Founder & Director at Apollo White Dental & Apollo Dialysis; and Anchor Investor at Stakeboat Capital, a private equity fund. He is also the Honorary Consul to The Republic of Estonia in India, wherein the Honorary Consul jurisdiction states include Tamil Nadu, Kerala, Andhra Pradesh and Telangana.

Expressing gratitude and talking about his role, Dr. GSK Velu, Chairman and Managing Director, Neuberg Diagnostics and Trivitron Healthcare said, “I am thankful for FICCI’s vote of confidence in appointing me as the Chairperson of FICCI Tamil Nadu State Council. This position gives me an opportunity to work within the FICCI framework in meeting its objectives of industry growth at one level, and the nation’s growth at another. I look forward to engaging with industry leaders to foster an ecosystem of innovation and growth, and towards building consensus between the industry and the policymakers.”

With more than 33 years of experience in the healthcare and diagnostics industry, Dr. Velu’s contributions and prominence in the healthcare sector has been recognized and received globally. He has been bestowed with several awards and accolades which are a testimony to his hard work, dedication and, his vision of making access to affordable quality healthcare, a reality.

City Today News
9341997936

MediBuddy closes $40 Million in Series B – the biggest round of funding in the Digital Healthcare space

Establishing MediBuddy as India’s No. 1 Digital Healthcare Platform

National, 2nd February 2021: MediBuddy, India’s leading digital healthcare platform announced the closure of its $40 Million Series B Round. This follows the recent infusion of $20 million led by India Life Sciences Fund ilI, LLC, with participation from other investors. The digital healthcare platform had earlier announced an initial funding of $20 million (INR 150 crores) in June 2020 under this round. MediBuddy is led by co-founders Mr. Satish Kannan & Mr. Enbasekar, as the CEO and the CTO, respectively.

COVID-19 has created an unprecedented acceleration in digital healthcare adoption and MediBuddy has been at the forefront of this transformation. To-date, over 3 crore Indians have used the mobile and web platforms to access specialist doctors 24×7 on video, order medicines and book home collection of lab samples. In addition, several Fortune 500 companies in India have trusted MediBuddy as their preferred digital healthcare partner to help their employees access various healthcare benefits.

In June 2020, to create market leadership in the digital healthcare industry, DocsApp (India’s leading online doctor consultation platform) merged with MediBuddy. Going forward, both MediBuddy and DocsApp will operate under a single brand name – MediBuddy.

Addressing the press conference, Mr. Satish Kannan, Co-Founder & CEO, MediBuddy, said, “At MediBuddy, we strive towards making high-quality healthcare accessible to Indians across the length & breadth of the country. On any given day, we provide consultations to more patients than any leading offline hospital chain. Moreover, we are proud of the fact that over 50% of these users are from non-urban areas.”

Mr. Kannan also added that the potential of the MediBuddy platform has generated significant investor interest in the Series B round despite the uncertainty prevalent worldwide, helping it secure the highest funding in the digital healthcare space since the start of the pandemic. He also said that the Series B round attracted new investments from India Life Sciences Fund III, LLC, TEAMFund LP, JAFCO Asia Fund, FinSight Ventures, ALES Global Japan and Beyond Next Ventures. Existing investors including Bessemer Venture Partners, Milliways Ventures and Rebright Partners also participated in this round.

Mr. Vishal Gupta, Managing Director, Bessemer Venture Partners India, said, “We are fortunate to have been part of Satish’s and Enba’s journey from the very early days. We continue to be strong supporters as they execute towards their aim of enabling more Indians to have access to high-quality healthcare.”

Mr. Vikul Goyal, Venture Partner, FinSight Ventures, said, “Telemedicine in India is growing at a monumental pace and the pandemic has only further amplified the importance of going digital. MediBuddy is by far the leader in the digital healthcare space in terms of scale, size & customers served; and we are excited to partner with MediBuddy in this growth journey to make high-quality healthcare accessible to a billion Indians.”

Mr. Devarajan TP, Managing Director, representative of India Life Sciences Fund III, LLC, on the Board, said, “The Fund is excited about partnering with MediBuddy and its dynamic leadership team with Satish and Enba at the helm. MediBuddy’s e-health platform enables customers access the entire gamut of healthcare services, be it tele-consultation services, lab tests or medicines, across devices. The Fund is particularly heartened by MediBuddy’s efforts at enabling such access in vernacular languages, which will be the key to meeting its mission of serving customers across the length and breadth of the country. Its marquee customer base, consisting of the India operations of several Fortune 500 companies, and many leading insurance companies, is testimony to the quality of services provided. The Fund’s representatives look forward to working with MediBuddy and supporting it in its endeavour to emerge as India’s preferred digital healthcare platform.”

Ms. Supriya Singh, Director, JAFCO Asia Fund, said, “The telemedicine market in India is a very large growing opportunity and MediBuddys in a very strong position in this market. They have the most comprehensive platform to address the market needs. JAFCO Asia has been one of the key investors in Teladoc in the US which 1s right now at USD 38bn in market cap. JAFCO Asia is very proud to be a partner to Satish and Enba in the growth journey for MediBuddy.”

Mr. Yousut Mazhar, Managing Partner, TEAMFund, said, “TEAMFund is very excited to partner with the team at MediBuddy, and is looking forward to helping build out their chronic disease management capabilities for remote patients. MediBuddy has built a first class, frictionless platform that integrates telehealth with essential lab and pharmaceutical services that we believe is amongst the best in the world. This is extremely valuable for patients across the country, and especially for those in rural and low resource areas who benefit from increased efficiency, lower cost, and increased access to specialized services.”

The digital healthcare platform will utilize the funding in further strengthening its doctor and hospital base, patlent reach, product, technology and brand to move a step closer to its mission of providing high-quality healthcare to a billion people. Additionally, the platform has onboarded leading industry professionals over the last few months to drive critical areas, bolstering an already-strong leadership team.

With a network of over 90,000 doctors, 7,000 haspitals, 3,000 diagnostic centres and 2,500 pharmacies, covering over 95% of all pin codes in India, MediBuddy is well-positioned to strengthen its leadership position by providing 24×7 access to a range of healthcare services across India. MediBuddy is truly living up to its name of being a ‘buddy’ who can be trusted to meet all your healthcare needs.

City Today News
9341997936

(citytoday.media)